(ABI) Anheuser Busch Inbev - Ratings and Ratios
Beer, Spirits, Beverages
ABI EPS (Earnings per Share)
ABI Revenue
Description: ABI Anheuser Busch Inbev
Anheuser-Busch InBev SA/NV is a multinational beverage company with a diverse portfolio of approximately 500 beer brands, including well-known labels such as Budweiser, Corona Extra, and Stella Artois, as well as spirits-based ready-to-drink and non-alcohol beverages. The companys global presence spans across North America, South America, Europe, Africa, and the Asia Pacific, making it a significant player in the global brewing industry.
From a financial perspective, ABI has a market capitalization of €114.19 billion, indicating its substantial size and market presence. The companys price-to-earnings (P/E) ratio is 20.39, while the forward P/E is 18.83, suggesting a relatively stable earnings outlook. Additionally, the return on equity (RoE) stands at 8.34%, indicating a moderate level of profitability.
To further analyze ABIs performance, key performance indicators (KPIs) such as revenue growth, gross margin, and dividend yield can be examined. The companys revenue growth has been driven by its diversified portfolio and global presence, with a gross margin of around 40-50% in recent years. ABIs dividend yield is approximately 2-3%, making it an attractive option for income-seeking investors. Furthermore, the companys debt-to-equity ratio is around 0.8-1.0, indicating a manageable level of leverage.
ABIs competitive position in the brewing industry is characterized by its strong brand portfolio, global distribution network, and significant marketing efforts. The companys ability to innovate and adapt to changing consumer preferences, such as the shift towards low-carb and low-calorie beverages, will be crucial in driving future growth. With a strong presence in emerging markets and a diversified product portfolio, ABI is well-positioned to capitalize on trends in the beverage industry.
ABI Stock Overview
| Market Cap in USD | 121,458m |
| Sub-Industry | Brewers |
| IPO / Inception |
ABI Stock Ratings
| Growth Rating | 21.8% |
| Fundamental | 59.9% |
| Dividend Rating | 59.2% |
| Return 12m vs S&P 500 | -15.9% |
| Analyst Rating | - |
ABI Dividends
| Dividend Yield 12m | 1.82% |
| Yield on Cost 5y | 2.18% |
| Annual Growth 5y | 10.40% |
| Payout Consistency | 86.2% |
| Payout Ratio | 27.4% |
ABI Growth Ratios
| Growth Correlation 3m | -87.1% |
| Growth Correlation 12m | 28.4% |
| Growth Correlation 5y | 40.9% |
| CAGR 5y | 3.19% |
| CAGR/Max DD 5y | 0.11 |
| Sharpe Ratio 12m | 0.51 |
| Alpha | -8.03 |
| Beta | 0.164 |
| Volatility | 25.92% |
| Current Volume | 780.5k |
| Average Volume 20d | 1197.2k |
| Stop Loss | 52.1 (-3.1%) |
| Signal | -1.92 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (7.12b TTM) > 0 and > 6% of Revenue (6% = 3.51b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 1.21pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -20.15% (prev -15.92%; Δ -4.23pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 15.05b > Net Income 7.12b (YES >=105%, WARN >=100%) |
| Net Debt (68.52b) to EBITDA (14.58b) ratio: 4.70 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.64 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.99b) change vs 12m ago -2.40% (target <= -2.0% for YES) |
| Gross Margin 55.70% (prev 54.48%; Δ 1.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 27.75% (prev 28.44%; Δ -0.69pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.27 (EBITDA TTM 14.58b / Interest Expense TTM 5.16b) >= 6 (WARN >= 3) |
Altman Z'' 1.33
| (A) -0.06 = (Total Current Assets 21.21b - Total Current Liabilities 33.01b) / Total Assets 211.11b |
| (B) 0.23 = Retained Earnings (Balance) 47.64b / Total Assets 211.11b |
| (C) 0.06 = EBIT TTM 11.69b / Avg Total Assets 210.91b |
| (D) 0.56 = Book Value of Equity 67.21b / Total Liabilities 119.69b |
| Total Rating: 1.33 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.86
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 5.95% = 2.98 |
| 3. FCF Margin 19.13% = 4.78 |
| 4. Debt/Equity 0.92 = 2.10 |
| 5. Debt/Ebitda 5.06 = -2.50 |
| 6. ROIC - WACC 0.58% = 0.73 |
| 7. RoE 8.45% = 0.70 |
| 8. Rev. Trend -17.00% = -0.85 |
| 9. Rev. CAGR -0.21% = -0.04 |
| 10. EPS Trend 13.67% = 0.34 |
| 11. EPS CAGR 6.21% = 0.62 |
What is the price of ABI shares?
Over the past week, the price has changed by -0.92%, over one month by -6.41%, over three months by -13.29% and over the past year by -1.02%.
Is Anheuser Busch Inbev a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ABI is around 47.65 EUR . This means that ABI is currently overvalued and has a potential downside of -11.37%.
Is ABI a buy, sell or hold?
What are the forecasts/targets for the ABI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67.9 | 26.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 51.4 | -4.4% |
ABI Fundamental Data Overview
Market Cap USD = 121.46b (104.27b EUR * 1.1648 EUR.USD)
CCE Cash And Equivalents = 7.27b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 17.8605
P/E Forward = 17.1821
P/S = 1.7819
P/B = 1.5212
P/EG = 1.4413
Beta = 0.867
Revenue TTM = 58.52b USD
EBIT TTM = 11.69b USD
EBITDA TTM = 14.58b USD
Long Term Debt = 70.23b USD (from longTermDebt, last quarter)
Short Term Debt = 3.60b USD (from shortTermDebt, last quarter)
Debt = 73.83b USD (Calculated: Short Term 3.60b + Long Term 70.23b)
Net Debt = 68.52b USD (from netDebt column, last quarter)
Enterprise Value = 188.03b USD (121.46b + Debt 73.83b - CCE 7.27b)
Interest Coverage Ratio = 2.27 (Ebit TTM 11.69b / Interest Expense TTM 5.16b)
FCF Yield = 5.95% (FCF TTM 11.19b / Enterprise Value 188.03b)
FCF Margin = 19.13% (FCF TTM 11.19b / Revenue TTM 58.52b)
Net Margin = 12.16% (Net Income TTM 7.12b / Revenue TTM 58.52b)
Gross Margin = 55.70% ((Revenue TTM 58.52b - Cost of Revenue TTM 25.93b) / Revenue TTM)
Tobins Q-Ratio = 2.80 (Enterprise Value 188.03b / Book Value Of Equity 67.21b)
Interest Expense / Debt = 2.76% (Interest Expense 2.04b / Debt 73.83b)
Taxrate = 29.83% (from yearly Income Tax Expense: 3.15b / 10.57b)
NOPAT = 8.20b (EBIT 11.69b * (1 - 29.83%))
Current Ratio = 0.64 (Total Current Assets 21.21b / Total Current Liabilities 33.01b)
Debt / Equity = 0.92 (Debt 73.83b / last Quarter total Stockholder Equity 80.67b)
Debt / EBITDA = 5.06 (Net Debt 68.52b / EBITDA 14.58b)
Debt / FCF = 6.60 (Debt 73.83b / FCF TTM 11.19b)
Total Stockholder Equity = 84.21b (last 4 quarters mean)
RoA = 3.37% (Net Income 7.12b, Total Assets 211.11b )
RoE = 8.45% (Net Income TTM 7.12b / Total Stockholder Equity 84.21b)
RoCE = 7.57% (Ebit 11.69b / (Equity 84.21b + L.T.Debt 70.23b))
RoIC = 5.43% (NOPAT 8.20b / Invested Capital 151.01b)
WACC = 4.85% (E(121.46b)/V(195.29b) * Re(6.62%)) + (D(73.83b)/V(195.29b) * Rd(2.76%) * (1-Tc(0.30)))
Shares Correlation 5-Years: -10.0 | Cagr: -0.15%
Discount Rate = 6.62% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈10.17b ; Y1≈12.54b ; Y5≈21.40b
Fair Price DCF = 210.3 (DCF Value 363.93b / Shares Outstanding 1.73b; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: -17.00 | Revenue CAGR: -0.21%
Rev Growth-of-Growth: -3.21
EPS Correlation: 13.67 | EPS CAGR: 6.21%
EPS Growth-of-Growth: 24.43